Synaptic Systems

Cat. No.: 284 006

Amount: 50 µg

Price: $385.00

For the import of chicken antibodies into the USA you need a special import permit. This can be applied for at your USDA office. If you cannot apply for this, please order the chicken antibodies through our distributor Cedarlane USA. If you have any questions, please contact us.

Cat. No. 284 006	50 µg specific antibody, lyophilized. Affinity purified with the immunogen. Albumin and azide were added for stabilization. For reconstitution add 50 µl H₂O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use. Antibodies should be stored at +4°C when still lyophilized. Do not freeze!
Applications	WB: not recommended IP: not tested yet ICC: not tested yet IHC: 1 : 500 gallery IHC-P: 1 : 500 (see remarks) gallery
Immunogen	Synthetic peptide corresponding to residues near the amino terminus of rat DAT (UniProt Id: P23977)
Reactivity	Reacts with: mouse (Q01959), rat (P23977). Other species not tested yet.
Remarks	IHC-P: Requires heat mediated antigen retrieval with 10 mM Tris pH 9.0, 1 mM EDTA and 0.05 % Tween 20.
Data sheet	284_006.pdf

References for DAT - 284 006

IHC (1)

INSIHGT: an accessible multi-scale, multi-modal 3D spatial biology platform.
Yau CN, Hung JTS, Campbell RAA, Wong TCY, Huang B, Wong BTY, Chow NKN, Zhang L, Tsoi EPL, Tan Y, Li JJX, et al.
Nature communications (2024) 151: 10888. 284 006 IHC; tested species: mouse

Cat. No.: 284 006

Amount: 50 µg

Price: $385.00

IHC

IHC-P

Background

The dopamine transporter (DAT), encoded by the SLC6A3 gene, plays a crucial role in regulating dopaminergic neurotransmission by facilitating the reuptake of dopamine (DA) from the synaptic cleft back into presynaptic neurons (1, 2). Structurally, DAT consists of 12 transmembrane domains with interspersed extracellular and intracellular loops. The N- and C-terminal regions of the protein are intracellular, providing multiple potential phosphorylation sites that regulate its activity (1, 3).
Functionally, DAT contributes to the termination of DA signaling by reuptaking DA, thereby controlling both the duration and magnitude of dopaminergic transmission (4). It is predominantly found in dopaminergic neurons and enriched in regions such as the striatum, substantia nigra, and ventral tegmental area, which are associated with motor control and reward mechanisms (5).
Alterations in DAT expression have been linked to various neuropsychiatric disorders, including Parkinson's disease and schizophrenia, emphasizing its importance in maintaining dopaminergic homeostasis and neuronal integrity (6, 7).

1 ) Giros B et al., Nature (1996)
2 ) Amara SG et al., Drug Alcohol Depend (1998)
3 ) Freed C et al., J Comp Neurol (1995)
4 ) Amara SG et al., Annu Rev Neurosci (1993)
5 ) Bu M et al., NPJ Parkinsons Dis (2021)
6 ) Koob GF et al., Science (1997)
7 ) Fusar-Poli P et al., Schizophr Bull (2013)

Protocols

Other products for this target

DAT antibody - 284 006

References for DAT - 284 006